MMAF-OMe
MMAF-Ome, an antitubulin agent, is also an ADC cytotoxin. MMAF-Ome inhibits several tumor cell lines with IC50s of 0.056 nM, 0.166 nM, 0.183 nM, and 0.449 nM for MDAMB435/5T4, MDAMB361DYT2, MDAMB468, and Raji (5T4-) cell lines, respectively.
Product Specifications
CAS Number
863971-12-4
Product Name Alternative
Monomethyl auristatin F methyl ester
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
ADC Payload
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/MMAF-OMe.html
Purity
99.62
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CC[C@H](C)[C@@H]([C@@H](CC(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(N[C@H](C(OC)=O)CC2=CC=CC=C2)=O)OC)=O)OC)N(C([C@H](C(C)C)NC([C@H](C(C)C)NC)=O)=O)C
Molecular Formula
C40H67N5O8
Molecular Weight
745.99
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
Auristatin
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Escherichia coli Probable lipid kinase YegS (yegS)
Recombinant Escherichia coli Probable lipid kinase YegS (yegS)
Recombinant Escherichia coli Probable lipid kinase YegS (yegS)
Recombinant Escherichia coli Probable lipid kinase YegS (yegS)